BR9501035A - Composto processo para a sua produção composição farmacêutica e uso do composto - Google Patents

Composto processo para a sua produção composição farmacêutica e uso do composto

Info

Publication number: BR9501035A
Authority: BR; Brazil
Prior art keywords: compound; pharmaceutical composition; composition production; silyl; hydroxy
Prior art date: 1994-03-11

Application number

BR9501035A

Other languages

English (en)

Inventor

Thomas L Doran

Shian-Jan Shiuey

Milan Radoje Uskokovic

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-11

Filing date

1995-03-10

Publication date

1995-10-31

1995-03-10 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1995-10-31 Publication of BR9501035A publication Critical patent/BR9501035A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)

BR9501035A 1994-03-11 1995-03-10 Composto processo para a sua produção composição farmacêutica e uso do composto BR9501035A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08212453 US5384314B1 (en)	1994-03-11	1994-03-11	1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Publications (1)

Publication Number	Publication Date
BR9501035A true BR9501035A (pt)	1995-10-31

Family

ID=22791087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9501035A BR9501035A (pt)	1994-03-11	1995-03-10	Composto processo para a sua produção composição farmacêutica e uso do composto

Country Status (22)

Country	Link
US (1)	US5384314B1 (pt)
EP (1)	EP0671387B1 (pt)
JP (1)	JP2659345B2 (pt)
KR (1)	KR100360732B1 (pt)
CN (1)	CN1051227C (pt)
AT (1)	ATE165595T1 (pt)
AU (1)	AU687972B2 (pt)
BR (1)	BR9501035A (pt)
CA (1)	CA2141652C (pt)
CZ (1)	CZ288793B6 (pt)
DE (1)	DE69502223T2 (pt)
DK (1)	DK0671387T3 (pt)
ES (1)	ES2116634T3 (pt)
FI (1)	FI112323B (pt)
HU (1)	HU219906B (pt)
IL (1)	IL112887A0 (pt)
NO (1)	NO307782B1 (pt)
NZ (1)	NZ270624A (pt)
PH (1)	PH31333A (pt)
PL (1)	PL179120B1 (pt)
RU (1)	RU2142803C1 (pt)
ZA (1)	ZA951798B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5830885A (en) *	1992-03-12	1998-11-03	The Johns Hopkins University	Antiproliferative vitamin D3 hybrids
US5696103A (en) *	1995-11-17	1997-12-09	Syntex (U.S.A.) Inc.	Method for treating osteoporosis
SG70010A1 (en) *	1996-05-23	2000-01-25	Hoffmann La Roche	Fluorinated vitamin d3 analogs
US5939408A (en)	1996-05-23	1999-08-17	Hoffman-La Roche Inc.	Vitamin D3 analogs
NO971934L (no) *	1996-05-23	1997-11-24	Hoffmann La Roche	Flourinerte vitamin D3 -analoger
US5840718A (en) *	1997-03-06	1998-11-24	Hoffmann-La Roche Inc.	22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
US6008209A (en) *	1997-04-28	1999-12-28	Hoffmann-La Roche Inc.	Method of using vitamin D3 analogs with bis C-20 side chains
DE69813380T2 (de) *	1997-05-02	2003-12-04	Duphar International Research B.V., Weesp	Verfahren zur Herstellung von 16-Dehydro Vitamin D Verbindungen
US5872113A (en) *	1997-05-16	1999-02-16	Syntex (U.S.A.) Inc.	Fluorinated vitamin D3 analogs
US5919986A (en) *	1997-10-17	1999-07-06	Hoffmann-La Roche Inc.	D-homo vitamin D3 derivatives
AU3390400A (en) *	1999-03-05	2000-09-21	Johns Hopkins University, The	Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
DE19935771A1 (de) *	1999-07-23	2001-02-01	Schering Ag	Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE10211555A1 (de) *	2002-03-15	2003-10-02	Imtm Inst Fuer Medizintechnolo	Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4188345A (en) *	1978-07-26	1980-02-12	Wisconsin Alumni Research Foundation	Fluorovitamin D compounds and processes for their preparation
JPS6340975A (ja) *	1986-08-05	1988-02-22	Mitsubishi Electric Corp	階調補正方式
US5087619A (en) *	1988-01-20	1992-02-11	Hoffman-La Roche Inc.	Vitamin D3 analogs
US5145846A (en) *	1988-01-20	1992-09-08	Hoffmann-La Roche Inc.	Vitamin D3 analogs
GB8915770D0 (en) *	1989-07-10	1989-08-31	Leo Pharm Prod Ltd	Chemical compounds
GB9004544D0 (en) *	1990-03-01	1990-04-25	Leo Pharm Prod Ltd	Novel treatment ii
GB9017890D0 (en) *	1990-08-15	1990-09-26	Leo Pharm Prod Ltd	Chemical compounds i
EP0580968B1 (en) *	1992-05-20	1996-08-28	F. Hoffmann-La Roche Ag	Vitamin D3 fluorinated analogs

1994
- 1994-03-11 US US08212453 patent/US5384314B1/en not_active Expired - Lifetime
1995
- 1995-02-01 CA CA002141652A patent/CA2141652C/en not_active Expired - Fee Related
- 1995-02-27 AT AT95102749T patent/ATE165595T1/de not_active IP Right Cessation
- 1995-02-27 DK DK95102749T patent/DK0671387T3/da active
- 1995-02-27 DE DE69502223T patent/DE69502223T2/de not_active Expired - Fee Related
- 1995-02-27 ES ES95102749T patent/ES2116634T3/es not_active Expired - Lifetime
- 1995-02-27 EP EP95102749A patent/EP0671387B1/en not_active Expired - Lifetime
- 1995-03-03 NZ NZ270624A patent/NZ270624A/en unknown
- 1995-03-03 ZA ZA951798A patent/ZA951798B/xx unknown
- 1995-03-06 JP JP7045420A patent/JP2659345B2/ja not_active Expired - Fee Related
- 1995-03-06 HU HU9500666A patent/HU219906B/hu not_active IP Right Cessation
- 1995-03-06 IL IL11288795A patent/IL112887A0/xx not_active IP Right Cessation
- 1995-03-06 AU AU13644/95A patent/AU687972B2/en not_active Ceased
- 1995-03-07 PH PH50068A patent/PH31333A/en unknown
- 1995-03-08 CN CN95102263A patent/CN1051227C/zh not_active Expired - Fee Related
- 1995-03-09 RU RU95103438A patent/RU2142803C1/ru active
- 1995-03-10 CZ CZ1995632A patent/CZ288793B6/cs not_active IP Right Cessation
- 1995-03-10 BR BR9501035A patent/BR9501035A/pt not_active IP Right Cessation
- 1995-03-10 NO NO950920A patent/NO307782B1/no not_active IP Right Cessation
- 1995-03-10 FI FI951134A patent/FI112323B/fi not_active IP Right Cessation
- 1995-03-10 PL PL95307629A patent/PL179120B1/pl unknown
- 1995-03-10 KR KR1019950004861A patent/KR100360732B1/ko not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR950032046A (ko)	1995-12-20
FI112323B (fi)	2003-11-28
RU95103438A (ru)	1997-02-10
CZ63295A3 (en)	1995-11-15
DK0671387T3 (da)	1998-10-07
JPH07258208A (ja)	1995-10-09
NO950920D0 (no)	1995-03-10
JP2659345B2 (ja)	1997-09-30
KR100360732B1 (ko)	2003-03-04
PL307629A1 (en)	1995-09-18
NO307782B1 (no)	2000-05-29
ATE165595T1 (de)	1998-05-15
AU687972B2 (en)	1998-03-05
US5384314A (en)	1995-01-24
DE69502223D1 (de)	1998-06-04
RU2142803C1 (ru)	1999-12-20
NO950920L (no)	1995-09-12
DE69502223T2 (de)	1998-10-29
EP0671387B1 (en)	1998-04-29
EP0671387A1 (en)	1995-09-13
CN1051227C (zh)	2000-04-12
IL112887A0 (en)	1995-06-29
PH31333A (en)	1998-07-06
AU1364495A (en)	1995-09-21
HU219906B (hu)	2001-09-28
CA2141652A1 (en)	1995-09-12
CZ288793B6 (cs)	2001-09-12
CA2141652C (en)	2006-05-09
FI951134A (fi)	1995-09-12
FI951134A0 (fi)	1995-03-10
HU9500666D0 (en)	1995-04-28
US5384314B1 (en)	1997-08-05
PL179120B1 (pl)	2000-07-31
ES2116634T3 (es)	1998-07-16
ZA951798B (en)	1996-08-14
CN1112918A (zh)	1995-12-06
NZ270624A (en)	1996-06-25
HUT70746A (en)	1995-10-30

Similar Documents

Publication	Publication Date	Title
DK1465626T3 (da)	2008-11-17	Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
BR9502707A (pt)	1996-06-04	Composto composição farmacêutica e método para o tratamento de uma afecção
MX9302214A (es)	1993-10-01	Derivados de taxol y proceso para su preparacion
BR9501035A (pt)	1995-10-31	Composto processo para a sua produção composição farmacêutica e uso do composto
FI972580A (fi)	1997-08-19	Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
PT772600E (pt)	2003-01-31	Compostos de imidazolilo substituido nas posicoes 1 e 2 para o tratamento da inflamacao
BR0212617A (pt)	2005-02-09	Compostos de pirazolila substituìdo para o tratamento de inflamação
NL980012I2 (nl)	2004-11-01	Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
BRPI0415179A (pt)	2006-11-28	derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
BRPI0114344B8 (pt)	2021-05-25	composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação
BR0215027A (pt)	2004-11-09	Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
AU2001262401A1 (en)	2001-11-26	Use of ellagic acid as anti-pollution cosmetic agent
RU94036749A (ru)	1996-10-10	Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащие их фармацевтические композиции и промежуточные соединения синтеза
BR9712141A (pt)	1999-08-31	Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
CA2267165A1 (en)	1998-04-02	Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
ES2164454T3 (es)	2002-02-16	Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen.
BR9907340A (pt)	2001-01-16	Ciclo-heptenos substituìdos, e processo para a produção de um composto
BR0317445A (pt)	2005-11-16	Composto, composição farmacêutica, método para o tratamento de doenças, e, uso de um composto
BR9812671A (pt)	2000-08-22	Tetrahidrofurano fosfato- e hidróxi ésteres, como pró-medicamentos para o correspondente agente antifúgico
PT930879E (pt)	2003-01-31	Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
DE60322343D1 (de)	2008-09-04	Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten
BR9807920A (pt)	2000-02-22	Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência
BR9915371A (pt)	2001-08-14	Processos para a preparação de um composto de 1, 4-diaril-2-fluoro-1, 3-butadieno e de um composto de 1, 4-diaril-2-fluoro-2-buteno
MY121344A (en)	2006-01-28	Formulated product
PT1237850E (pt)	2005-06-30	Glioxilamidas, processo para a sua preparacao e sua utilizacao para o combate de organismos prejudiciais

Legal Events

Date	Code	Title	Description
2002-08-20	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2002-12-24	HJEG	Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
2004-01-06	FF	Decision: intention to grant
2004-04-13	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
2011-04-26	B24C	Patent annual fee: request for for restoration	Free format text: REFERENTE A 11A , 12A , 13A , 14A , 15A E 16A A NUIDADES.
2011-08-09	B24G	Patent annual fee: republication	Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2103 DE 26/04/2011 CUJO TEOR PASSA A SER: " REFERENTE A 12A, 13A, 14A, 15A E 16A ANUIDADES".
2012-05-02	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE AO(S) DESPACHO(S) 24.7 E 24.3 PUBLICADO(S) NA(S) RPI(S) 2118 DE 09/08/2011 E 2103 DE 26/04/2011, RESPECTIVAMENTE.